CLINICAL DECISION SUPPORT SYSTEMS TO OPTIMIZE ADHERENCE TO ANTICOAGULANT GUIDELINES IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Clinical decision support systems to optimize adherence to anticoagulant guidelines in patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials

Clinical decision support systems to optimize adherence to anticoagulant guidelines in patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials

Blog Article

Abstract Background Clinical decision support systems (CDSS) have been utilized as a low-cost intervention to improve healthcare process measures.Thus, we aim to estimate CDSS efficacy to optimize adherence to oral anticoagulant guidelines in eligible patients with HDMI Adaptors atrial fibrillation (AF).Methods A systematic review and meta-analysis of randomized controlled trials (RCTs) retrieved from PubMed, WOS, SCOPUS, EMBASE, and CENTRAL through August 2023.

We used RevMan V.5.4 to pool dichotomous data using risk ratio (RR) with a 95% confidence interval (CI).

PROSPERO ID: CRD42023471806.Results We included nine RCTs with a total of 25,573 patients.There was no significant difference, with the use of CDSS compared to routine care, in the number of patients prescribed anticoagulants (RR: 1.

06, 95% CI [0.98, 1.14], P = 0.

16), the number of patients prescribed antiplatelets (RR: 1.01 with 95% CI [0.97, 1.

06], P = 0.59), all-cause mortality (RR: 1.19, 95% CI [0.

31, 4.50], P = 0.80), major bleeding (RR: 0.

84, 95% CI [0.21, 3.45], P = 0.

81), and clinically relevant non-major bleeding (RR: 1.05, 95% CI [0.52, Henry Blooms 2.

16], P = 0.88).However, CDSS was significantly associated with reduced incidence of myocardial infarction (RR: 0.

18, 95% CI [0.06, 0.54], P = 0.

002) and cerebral or systemic embolic event (RR: 0.11, 95% CI [0.01, 0.

83], P = 0.03).Conclusion We report no significant difference with the use of CDSS compared to routine care in anticoagulant or antiplatelet prescription in eligible patients with AF.

CDSS was associated with a reduced incidence of myocardial infarction and cerebral or systemic embolic events.

Report this page